Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Long-Term Debt Repayments (2016 - 2024)

Orthopediatrics has reported Long-Term Debt Repayments over the past 7 years, most recently at $11.3 million for Q3 2024.

  • Quarterly results put Long-Term Debt Repayments at $11.3 million for Q3 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was $11.7 million (down 4.4% YoY), and the annual figure for FY2024 was $12.2 million, changed.
  • Long-Term Debt Repayments for Q3 2024 was $11.3 million at Orthopediatrics, up from $390000.0 in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for KIDS hit a ceiling of $11.3 million in Q3 2024 and a floor of -$102000.0 in Q4 2022.
  • Median Long-Term Debt Repayments over the past 3 years was $34000.0 (2022), compared with a mean of $1.1 million.
  • Peak annual rise in Long-Term Debt Repayments hit 154.69% in 2022, while the deepest fall reached 177.86% in 2022.
  • Orthopediatrics' Long-Term Debt Repayments stood at $131000.0 in 2021, then plummeted by 177.86% to -$102000.0 in 2022, then soared by 11181.37% to $11.3 million in 2024.
  • The last three reported values for Long-Term Debt Repayments were $11.3 million (Q3 2024), $390000.0 (Q2 2024), and $538000.0 (Q1 2024) per Business Quant data.